Category:

In its COVID-19 vaccine patent kerfuffle with Arbutus Biopharma and Roivant’s Genevant Sciences, mRNA hot shot Moderna aims to shield itself with its government contract...Plaintiffs Arbutus and Genevant sued Moderna back in February, seeking damages tied to six patents they claim Moderna infringed with the production and sale of its COVID-19 vaccine Spikevax...the plaintiffs should have sued the U.S. government instead, Moderna said in a filing at the U.S. District Court for Delaware. To back up its argument, Moderna cited a federal law once used to “’prevent patent infringement suits from interfering with the supply of war materials during World War 1.'”...Moderna explained that it supplied its COVID-19 vaccine to the feds as part of the nation’s emergency response to the pandemic. It's "difficult to conceive of a situation more within the heart" of the wartime law than the pandemic, the company argued...READ MORE

Cannabis is illegal federally – classified as a Schedule I controlled substance – but even state law, despite cannabis being legal to use in Nevada, maintains cannabis as a Schedule I drug alongside methamphetamine, heroin and cocaine...The Nevada State Board of Pharmacy continues to list cannabis as a Schedule I substance, and that listing prompted a lawsuit this week by the ACLU of Nevada seeking to get cannabis removed from the list...“For cannabis to be classified as a Schedule I substance, the Board of Pharmacy must find that it has no accepted medical use in treatment or it cannot be safely distributed to the public,” ACLU representatives said. “However, the Nevada Constitution explicitly allows for the ‘use by a patient, upon the advice of his physician, of a plant of the genus Cannabis for the treatment or alleviation of cancer, glaucoma, acquired immunodeficiency syndrome… or other chronic or debilitating medical conditions.’”...The ACLU alleges the pharmacy board’s classification continues to waste taxpayer dollars by continuing criminal convictions against those using and possessing cannabis...READ MORE

West Virginia's attorney general on Monday urged a judge to hold Johnson & Johnson , Teva Pharmaceuticals Industries Ltd, and AbbVie Inc's, Allergan liable for causing a "tsunami" of opioid addiction in the state...The addiction crisis has affected the state's police forces, hospitals, foster care system and jails, with effects that will linger for more than a generation, Attorney General Patrick Morrisey said..."This epidemic has impacted virtually all of West Virginia," Morrisey said. "Our lawsuit speaks for all West Virginians who have suffered due to the defendants' unlawful, callous and destructive conduct."...READ MORE

Less than three weeks after two companies sued Moderna, claiming the vaccine maker infringed on their patents in developing its COVID-19 shot, Alnylam has done the same, suing Moderna and Pfizer in separate lawsuits...In...federal court, Alnylam filed claims against the two COVID-19 vaccine producers alleging that more than a decade ago it invented the delivery technology employed by both shots...Alnylam says its Patent No. 11,246,933 covers “a breakthrough class of cationic biodegradable lipids used to form lipid nanoparticles that carry and safely deliver” mRNA-based vaccines...Alnylam is not attempting to halt production of the vaccines, it is seeking damages for the “defendants’ wrongful acts in an amount to be determined at trial” and royalties...READ MORE

A federal judge in Las Vegas said Monday he’ll decide in three weeks whether to dismiss a condemned Nevada killer’s lawsuit challenging the state’s plan for his lethal injection, because the state doesn’t have one of the drugs it would use...U.S. District Judge Richard Boulware II acknowledged during a brief hearing with attorneys for the state and the inmate, Zane Michael Floyd, that key questions about the execution method remain unanswered following weeks of testimony late last year...But the Nevada Department of Corrections supply of the sedative ketamine expired on Feb. 28, and Randall Gilmer, chief deputy state attorney general, said prison officials have been unable to get more...READ MORE

Most of the defendants in Florida’s lawsuit over the opioid epidemic have settled for more than $870 million, according to the state attorney general. One remains: Walgreens Co. is not giving up...A jury has been seated in Pasco County, Florida, just north of Tampa, to hear the state’s case against Walgreens, a huge drug store chain with more than 9,000 outlets on streetcorners throughout the country. Opening statements are set for early next week...The Deerfield, Illinois-based company says it will not settle...“We are prepared for trial,” said Walgreens spokesman Fraser Engerman in an email...READ MORE

Florida has reached more than $878 million in settlements with CVS Health Corp and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic in the third most populous U.S. state...CVS will pay $484 million, Teva Pharmaceutical Industries Ltd will pay $194.8 million, Abbvie Inc's, Allergan unit will pay $134.2 million and Endo International Plc will pay $65 million, Florida's attorney general Ashley Moody said in a statement...Most of the money will be spent on opioid abatement. Teva will also provide $84 million of its generic Narcan nasal spray...READ MORE

Law firm Kessler Topaz Meltzer & Check LLP on Sunday said it had filed a securities class action lawsuit against pharmaceutical company Natera Inc on behalf of shareholders...The law firm said the main justification for the lawsuit filed in the U.S. district court of the Western district of Texas was that Natera, which specializes in genetic testing and diagnostics, provided information about the efficacy of its tests that have not proved accurate..."Natera said that its tests are much more reliable than it appears they really are," Kessler Topaz said in the statement...READ MORE

Attorney General Aaron Ford joined representatives from the state health department and several local governments...to announce that Nevada will soon receive its first installment of money from a pair of major opioid settlements and to highlight the urgency of using those dollars to address the opioid crisis...the state will receive $50 million from two settlements announced by the attorney general’s office earlier this year. The settlements include one with opioid manufacturer Johnson & Johnson that will bring Nevada $53.5 million and another with three of the nation’s largest drug distributors — AmerisourceBergen, Cardinal Health and McKesson — that will bring the state $231.7 million. Those funds add to the $45 million the state won last year through a settlement with consulting firm McKinsey & Company...READ MORE

The Nevada Supreme Court ruled...that the state’s public records law does not require the disclosure of drug pricing information that could violate a federal trade secrets law, affirming a lower court ruling...Weighing laws and regulations that allow businesses to keep competitive records confidential, the court’s order limits the public release of information on high insulin prices, including the cost of producing diabetes drugs, administrative expenses and profits reaped by drug companies...The dispute over drug transparency records stems from a 2017 law...The statute required diabetes drug manufacturers and other companies involved in pricing, known as pharmacy benefit managers, to disclose information about pricing for insulin...READ MORE